pfizer covid - Search News

News

FDA, Pfizer and COVID-19

FDA signals it may revoke approval of Pfizer's pediatric COVID vaccine, leaving kids fewer options

The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children under the age of 5, according to multiple outlets.

CNBC on MSN · 2d

FDA may pull authorization of Pfizer's Covid vaccine for children under 5, company says

The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots against Covid.

USA TODAY on MSN · 19h

FDA may revoke Pfizer COVID-19 shot for young, healthy children.

Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.

2hon MSN

Got the sniffles? Here’s what to know about summer colds and the COVID-19 variant called stratus

COVID-19 activity is rising in much of the country. Data shows overall respiratory virus spread is very low in the U.S.

1don MSN

Vaccinating young children against Covid-19 may be more challenging this respiratory virus season

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

13don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

MedPage Today6d

Did FDA Pick the Wrong COVID Vaccine Strain Last Season? | MedPage Today

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...

RTHK News6d

Settlement reached over Covid-19 vaccines

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain's GSK and Germany's CureVac US$740 ...

6don MSN

CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results